DONATE

IBEC researchers are part of the European ATTRACT Project to develop a diagnostic device to improve embryo selection for in vitro fertilization procedures

HYLIGHT Project, coordinated by Samuel Ojosnegros from IBEC, was selected by the ATTRACT Phase 2, an initiative of the European Union to boost the transfer of deep technology with great potential to transfer from the laboratories to the society. The project was financed with around 2M euros for 26 months and aims to develop a diagnostic device to select embryos based on their metabolic profiles and increase the success rates of in vitro fertilization techniques.

A new tool against breast cancer: 3D bioprinted tumors using pig tissue 

Researchers at IBEC manage to recreate the complex composition of human breast tumors in the laboratory using tissues from female pig breasts. This new model will allow, among other applications, the production of artificial tumors to study the development of cancer and metastasis, and immunosuppression processes, as well as being an excellent platform for testing drugs against the disease. 

El IBEC recibe cerca de un millón de euros para estudiar las enfermedades respiratorias graves causadas por virus

El projecto REACT, liderado por el Statens Serum Institut de Dinamarca, cuenta con la participación del Instituto de Bioingeniería de Cataluña (IBEC) que, con un presupuesto cercano al millón de euros de un total de siete, generará organoides epiteliales nasales humanos específicos como plataformas de validación y modelos preclínicos para investigar la interacción huésped-patógeno .

Laboratory Technician at the Molecular and cellular neurobiotechnology Research Group


Application Deadline: 22/07/2022
Ref: LT_TR

The Molecular and cellular neurobiotechnology group at the Institute for Bioengineering of Catalonia (IBEC) is looking for Laboratory Technician to contribute to the development of novel methods for Neurodegenerative studies using microfluidics and in vitro platforms.

The contract will be within the framework of the project “Fabrication of novel microfluidic devices and applications to monitor tau-related neurodegeneration in vitro”.